Note dell’episodio
Four rival pharma companies build AI startups together. The science is rarely what decides which ones succeed.
You've built a model that works on public data. Now pharma wants a security review, a test you can't design yourself, and proof your tool fits a program they already run.
Yair Benita is CTO of AION Labs, a venture studio owned by Teva, Merck, Pfizer, AstraZeneca and AWS that builds AI drug discovery companies from scratch. His career runs from immuno-oncology at Merck in the early Keytruda days to immune checkpoint discovery at Compugen and patient data work at CytoReason.
Ross…
Sito web: corrdyn.com

